Pulsed radiofrequency neuromodulation of subchondral bone in knee osteoarthritis
9 affiliations
- 1Brazilian Institute of Regenerative Medicine (BIRM), Indaiatuba, São Paulo, Brazil
- 2Orthoregen International Course, Indaiatuba, São Paulo, Brazil
- 3Anna Vitória Lana Institute (IAVL), Indaiatuba, São Paulo, Brazil
- 4Max Planck University Center (UniMAX), Indaiatuba, São Paulo, Brazil
- 5Jaguariúna University Center (UNIFAJ), Jaguariúna, São Paulo, Brazil
- 6Federal University of Tocantins (UFT), Palmas, Tocantins, Brazil
- 7FC Sports Traumatology, Salvador, Bahia, Brazil
- 8Clínica de Dor, Porto, Portugal
- 9Independent Pain Practice, Amsterdam, Netherlands
Abstract
Bone marrow lesions (BMLs) on magnetic resonance imaging (MRI) are associated with pain and structural progression in knee osteoarthritis (OA), yet no approved therapy targets the subchondral bone compartment with a demonstrated structural effect. We hypothesize that a pulsed radiofrequency (PRF) electrode positioned percutaneously within the subchondral trabecular bone of the medial tibial plateau may modulate a local sensory nerve-osteoclast-osteoblast circuit that sustains the BML, reducing both pain and lesion volume. The rationale combines four observations, most of them obtained in settings other than human OA. First, subchondral bone is innervated by peptidergic sensory fibers, which in human OA accompany vascular channels across the osteochondral junction, and in murine OA, osteoclasts induce sensory nerve growth into subchondral bone. Second, in genetic mouse models, sensory nerve ablation reduces bone volume and sensory knockout of EP4 or TrkA attenuates load-induced bone formation. Third, a PRF electrode generates electric fields of the order of hundreds of V/cm within millimeters of its tip, at least four orders of magnitude above the fields of 0.07 to about 2 mV/cm induced in bone-cell studies of pulsed electromagnetic fields (PEMF); the benchmark electroporation threshold comes from a non-neuronal cell line and requires bone-specific validation. Fourth, one uncontrolled series of ten patients with femoral head osteonecrosis shows that intraosseous PRF electrode placement is technically feasible, but it reported neither pain scores nor adverse-event data and does not establish safety. We specify a staged program: bone-specific electrothermal modeling and ex vivo dosimetry; a randomized, blinded, sham-controlled study in the murine destabilization of the medial meniscus model with functional neuronal readouts and targeted sensory denervation; large-animal dosimetry; and a human feasibility study followed by an external pilot randomized trial using quantitative BML volumetry. Prespecified predictions define success, failure, and inconclusive results. The nerve growth factor (NGF)-TrkA axis, the proposed mediator, carries an internal paradox: NGF appears reparative in necrotic bone but sensitizing in osteoarthritic joints, and anti-NGF treatment relieves OA pain while worsening subchondral bone and cartilage in an animal model. Determining which effect predominates is the central test of this proposal.
Related
- From MRI-defined bone marrow lesions to pain, structural progression, and subchondral remodeling in knee osteoarthritis: an integrated multi-database bibliometric and text-mining analysis
- Neural crosstalk between subchondral bone and synovium in osteoarthritis
- The emerging role of subchondral bone homeostasis in osteoarthritis.
- Subchondral bone remodeling in knee osteoarthritis is coupled to lipid mobilization from bone marrow adipocytes
- Pulsed Field Versus Radiofrequency Ablation For Repeat Ablation of Atrial Fibrillation: Evaluation of Outcomes
BibTeX
@article{lana2026pulsed,
title = {{Pulsed radiofrequency neuromodulation of subchondral bone in knee osteoarthritis}},
author = {José Fábio Lana and Daniel Jorge and João Protásio Netto and Alex Pontes de Macedo and Luyddy Pires and Fábio Costa and Tomás Mosaner and Pablo Sobreiro and Douglas Santos and Alexandre Teixeira and Olav Rohof},
journal = {Frontiers in Pain Research},
year = {2026},
month = oct,
doi = {10.3389/fpain.2026.1968444},
url = {https://doi.org/10.3389/fpain.2026.1968444},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Pulsed radiofrequency neuromodulation of subchondral bone in knee osteoarthritis
AU - José Fábio Lana
AU - Daniel Jorge
AU - João Protásio Netto
AU - Alex Pontes de Macedo
AU - Luyddy Pires
AU - Fábio Costa
AU - Tomás Mosaner
AU - Pablo Sobreiro
AU - Douglas Santos
AU - Alexandre Teixeira
AU - Olav Rohof
PY - 2026
DA - 2026/10/21
JO - Frontiers in Pain Research
DO - 10.3389/fpain.2026.1968444
UR - https://doi.org/10.3389/fpain.2026.1968444
AB - Bone marrow lesions (BMLs) on magnetic resonance imaging (MRI) are associated with pain and structural progression in knee osteoarthritis (OA), yet no approved therapy targets the subchondral bone compartment with a demonstrated structural effect. We hypothesize that a pulsed radiofrequency (PRF) electrode positioned percutaneously within the subchondral trabecular bone of the medial tibial plateau may modulate a local sensory nerve-osteoclast-osteoblast circuit that sustains the BML, reducing both pain and lesion volume. The rationale combines four observations, most of them obtained in settings other than human OA. First, subchondral bone is innervated by peptidergic sensory fibers, which in human OA accompany vascular channels across the osteochondral junction, and in murine OA, osteoclasts induce sensory nerve growth into subchondral bone. Second, in genetic mouse models, sensory nerve ablation reduces bone volume and sensory knockout of EP4 or TrkA attenuates load-induced bone formation. Third, a PRF electrode generates electric fields of the order of hundreds of V/cm within millimeters of its tip, at least four orders of magnitude above the fields of 0.07 to about 2 mV/cm induced in bone-cell studies of pulsed electromagnetic fields (PEMF); the benchmark electroporation threshold comes from a non-neuronal cell line and requires bone-specific validation. Fourth, one uncontrolled series of ten patients with femoral head osteonecrosis shows that intraosseous PRF electrode placement is technically feasible, but it reported neither pain scores nor adverse-event data and does not establish safety. We specify a staged program: bone-specific electrothermal modeling and ex vivo dosimetry; a randomized, blinded, sham-controlled study in the murine destabilization of the medial meniscus model with functional neuronal readouts and targeted sensory denervation; large-animal dosimetry; and a human feasibility study followed by an external pilot randomized trial using quantitative BML volumetry. Prespecified predictions define success, failure, and inconclusive results. The nerve growth factor (NGF)-TrkA axis, the proposed mediator, carries an internal paradox: NGF appears reparative in necrotic bone but sensitizing in osteoarthritic joints, and anti-NGF treatment relieves OA pain while worsening subchondral bone and cartilage in an animal model. Determining which effect predominates is the central test of this proposal.
SN - 2673-561X
ER -